Michael Collins is hoping that his Newry City career will continue the way it has begun.
Signed two weeks ago from Portadown, the 30-year-old made his first appearance in the colours of the border club in a reserve outing and made a perfect start with his new club.
Not known for his scoring ability, Collins has already got his name onto the goalscoring charts.
He capped off an assured performance against Cliftonville Olympic by heading home the winning goal 10 minutes from time as City's second string came from a goal down to claim a 2-1 victory on Tuesday night.
"It was good to get playing again," said Collins.
"It's a month since I was sent-off against Lisburn Distillery in what was my last match for Portadown and I haven't even trained that much since.
"I tired towards the end of the game, which was probably to be expected, but I felt good and now it's about getting more games under my belt during the next month to get myself back up to full match fitness."
Collins is not allowed to play in the Premier League until the transfer window opens on New Year's Day.
Players can only be registered to play in reserve fixtures and Newry manager Gerry Flynn will give his latest signing another run out against Linfield Swifts on Saturday.
He is scheduled to fit in three more matches before being eligible for his first-team debut for the club against Lisburn Distillery on January 1.
"It is a bit frustrating that I can't play in the first-team because when you sign for a new club you want to show what you can do straight away," said Collins.
"I knew the situation when I came though and I could have stayed at Portadown and hoped to play in the first-team there.
"Playing reserve team football for a month doesn't bother me. I am getting to know the lads and hopefully I will be fit and sharp when the New Year comes around.
"I don't know if I will keep scoring, but it's a good way for me to start things off.
"I would be keen to keep getting a few goals but as long as the Newry teams rack up the wins that is the important thing overall."